Asan Medical Center is a hospital in Seoul, South Korea. It was established to put into practice the founding principles of Asan Foundation founder Chung Ju-Yung. It opened on June 23, 1989, under the name Seoul Jungang Hospital, and was renamed Asan Medical Center on April 27, 2002.

There are 2,715 beds in Asan Medical Center - Oncology.

During the past decade, Asan Medical Center - Oncology conducted 23 clinical trials. In the 10-year time frame, 23 clinical trials started and 22 clinical trials were completed, i.e. on average, 95.7% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 6 clinical trials were completed. i.e. 60% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Asan Medical Center - Oncology" #1 sponsor was "Hoffmann-La Roche" with 20 trials, followed by "Genentech, Inc." with 7 trials sponsored, "Pfizer" with 4 trials sponsored, "Seagen Inc." with 3 trials sponsored and "BeiGene" with 3 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Asan Medical Center - Oncology" #1 collaborator was "Genentech, Inc." with 2 trials as a collaborator, "Fondazione Italiana Linfomi ONLUS" with 1 trials as a collaborator and "Hoffmann-La Roche" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Asan Medical Center - Oncology" are "Gastric Cancer" (4 trials), "Neoplasms" (4 trials), "Breast Cancer" (3 trials), "Breast Neoplasms" (3 trials) and "Colorectal Cancer" (3 trials). Many other conditions were trialed in "Asan Medical Center - Oncology" in a lesser frequency.

Most popular intervention types in "Asan Medical Center - Oncology" are "Drug" (42 trials), "Other" (4 trials), "Biological" (1 trials), "Procedure" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "Capecitabine" (5 trials), "Docetaxel" (5 trials), "Pertuzumab" (5 trials) and "Trastuzumab" (5 trials). Other intervention names were less common.

The vast majority of trials in "Asan Medical Center - Oncology" are 40 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Asan Medical Center - Oncology". undefined are not yet recruiting, 5 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 26 completed trials in Asan Medical Center - Oncology, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Asan Medical Center - Oncology, 6 "Phase 1" clinical trials were conducted, 14 "Phase 2" clinical trials and 23 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".